Less Ads, More Data, More Tools Register for FREE

Pin to quick picksArgentex Group. Regulatory News (AGFX)

  • This share is currently suspended. It was suspended at a price of 2.45
  • There is currently no data for AGFX

Trading Statement

12 Oct 2020 07:00

RNS Number : 6887B
Argentex Group PLC
12 October 2020
 

 

 

12 October 2020

 

Argentex Group PLC

 

Trading Update

Argentex Group PLC, ("Argentex", "the Group", "the Company"), the provider of bespoke foreign exchange services to institutions, corporates and high net worth individuals, today issues a trading update for the first half of the financial year ending 30 September 2020.

Argentex LLP, the Group's FCA regulated trading subsidiary, expects to report revenues for the six-month period to 30 September 2020 of £11.8 million. The 14.7% decrease in revenue vs the six months ending 30 September 2019 (£13.8 million) was primarily driven by a reduction in client activity, as the continued macro-economic uncertainty and the effects of the COVID-19 pandemic led to some clients deferring their trading activity.

This deferral of trading activity is expected to result in stronger trading volumes in the second half of the financial year. The underlying business performed well during the period as the Group added a significant number of new customers as it continued to focus on increasing the quality and diversification of its client book, while also turning down trades that exceeded the Group's risk appetite in order to maintain the integrity of its exposure profile.

The Group has delivered an increase in the rate of new client acquisition of 87% compared to the same period last year and further progressed its long-term growth strategy when it opened its new London headquarters in September, delivering on its commitments of investing in new talent across the business, including a 62% increase in sales staff.

The strong momentum in customer growth during the first half of the financial year along with the expected uptick in trading from the existing client base gives the Directors confidence that the results for the second half, traditionally the slightly stronger half, will deliver a material improvement on the first half results.

Harry Adams, Co-CEO commented: "As the long-term impact of the COVID pandemic on global markets continues to be laid bare, it has never been more important to stand by our clients and ensure their growing FX trading needs are met. Despite frustrations over the drop in trading activity throughout the period I'm proud of how our people have adapted and delivered for our clients. Whilst clients delaying their trading activity has impacted our revenues, each of them has a commercial need to remove FX risk, so we expect a significant backlog of client volumes to be realised, the timing of which will likely depend on market and geopolitical events."

Carl Jani, Co-CEO said "The strong underlying performance of the business - notably the marked elevation of new client acquisition - is testament to our focused, long-term approach. In the face of a surge of client interest, we have focused on the quality of revenue over trading volume, remaining true to our strict risk management processes. Due to strong business fundamentals we have confidence in our ability to weather the uncertain environment, supported by a new office, a growing and increasingly talented workforce and a business model with proven resilience."

Argentex will be reporting its interim results for the six months ended 30 September 2020 on 20 November 2020.

For further information please contact:

 

Argentex Group PLC

Carl Jani, Harry Adams - Co-CEOs

(Via FTI Consulting)

 

FTI Consulting (Financial PR)

Ed Berry / Shiv Talwar / Ambrose Fullalove

Telephone: 07703 330 199

argentex@fticonsulting.com

 

Numis Securities Limited (Nominated Adviser and Broker)

Stephen Westgate, Charlie Farquhar, Laura White, Hugo RubinsteinTelephone: +44 (0) 20 7260 1000

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTZKLFBBBLXFBX
Date   Source Headline
26th Oct 20237:00 amRNSBoard Change
13th Sep 20237:00 amRNSInterim results for the six months to 30 June 2023
19th Jul 20232:36 pmRNSTR1 Disclosure - Gresham House Asset Management
18th Jul 20237:00 amRNSNotice of Interim Results
12th Jul 202312:55 pmRNSDirector / PDMR Dealing
10th Jul 20237:00 amRNSHalf year trading update and board changes
27th Jun 202312:20 pmRNSTR1 Notification
22nd Jun 20239:46 amRNSResult of AGM
20th Apr 20235:05 pmRNSPublication of Annual Report and Notice of AGM
12th Apr 20237:00 amRNSFull results for the 9 months to 31 December 2022
30th Mar 20237:00 amRNSNotice of Results and Presentations
13th Mar 20237:00 amRNSUpdate on counterparties
28th Feb 20237:00 amRNSBoard Announcement
26th Jan 20237:00 amRNSTrading Statement
12th Dec 20227:00 amRNSTrading Statement
17th Nov 20222:08 pmRNSDirector/PDMR Shareholding
10th Nov 20227:00 amRNSGrant of Awards Under New LTIP
8th Nov 202212:55 pmRNSNew Long Term Incentive Plan
8th Nov 20227:00 amRNSInterim Results
12th Oct 20227:00 amRNSNotice of Interim Results
3rd Oct 20227:00 amRNSTrading Update
23rd Sep 20226:05 pmRNSHolding(s) in Company
16th Sep 20227:00 amRNSNetherlands Electronic Money Licence granted
9th Sep 20221:10 pmRNSHolding(s) in Company
22nd Aug 20221:59 pmRNSResult of AGM
15th Jul 20227:00 amRNSPublication of Annual Report and Notice of AGM
6th Jul 20227:00 amRNSFull year results for period ended 31 March 2022
31st May 20227:00 amRNSNotice of Results
12th Apr 20227:00 amRNSTrading Update
8th Nov 20217:00 amRNSInterim Results
1st Nov 20217:00 amRNSInterim Results Presentations
11th Oct 20217:00 amRNSTrading Statement
27th Aug 20215:21 pmRNSHolding(s) in Company
13th Aug 20212:16 pmRNSHolding(s) in Company
12th Aug 20214:09 pmRNSHolding(s) in Company
12th Aug 20213:09 pmRNSHolding(s) in Company
12th Aug 20213:08 pmRNSHolding(s) in Company
11th Aug 20211:08 pmRNSHolding(s) in Company
11th Aug 20219:41 amRNSDirector/PDMR Shareholding
4th Aug 20216:08 pmRNSResult of AGM
29th Jul 20217:00 amRNSChange to AGM Arrangements
13th Jul 202112:04 pmRNSHolding(s) in Company
12th Jul 20217:00 amRNSPublication of Annual Report and Notice of AGM
5th Jul 20212:22 pmRNSHolding(s) in Company
1st Jul 20217:00 amRNSFull year results for period ending 31 March 2021
22nd Jun 20217:00 amRNSNotice of Results
11th Jun 20217:00 amRNSDirectorate Change
10th May 20217:00 amRNSManagement team update
12th Apr 20218:00 amRNSExtension of audit partner's tenure & audit tender
6th Apr 20217:00 amRNSTrading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.